VKTX · earnings call history
Viking Therapeutics Q2 FY26 — Pipeline Advancement and Organizational Growth
Read the briefViking Therapeutics Q1 FY26 — Pipeline Advancements and Oral Program Expansion
Read the briefBrowse all US companies on the earnings-call register.